QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-reiterates-overweight-on-inspire-medical-systems-lowers-price-target-to-135

Piper Sandler analyst Adam Maeder reiterates Inspire Medical Systems (NYSE:INSP) with a Overweight and lowers the price targ...

 rbc-capital-maintains-outperform-on-inspire-medical-systems-lowers-price-target-to-125

RBC Capital analyst Shagun Singh maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the price target...

 truist-securities-reiterates-hold-on-inspire-medical-systems-lowers-price-target-to-84

Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and lowers the price t...

 jp-morgan-maintains-neutral-on-inspire-medical-systems-lowers-price-target-to-82

JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and lowers the price target fro...

 wells-fargo-upgrades-inspire-medical-systems-to-overweight-lowers-price-target-to-90

Wells Fargo analyst Larry Biegelsen upgrades Inspire Medical Systems (NYSE:INSP) from Equal-Weight to Overweight and lowers ...

 inspire-medical-systems-raises-fy2025-gaap-eps-guidance-from-040-050-to-090-100-vs-045-est-affirms-fy2025-sales-guidance-of-900000m-910000m-vs-903814m-est

Inspire Medical Systems (NYSE:INSP) raises FY2025 GAAP EPS guidance from $0.40-$0.50 to $0.90-$1.00 vs $0.45 analyst estimate. ...

 inspire-medical-systems-q3-adj-eps-038-beats-019-estimate-sales-224501m-beat-220467m-estimate

Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of...

 jefferies-downgrades-inspire-medical-systems-to-hold-lowers-price-target-to-85

Jefferies analyst Michael Sarcone downgrades Inspire Medical Systems (NYSE:INSP) from Buy to Hold and lowers the price targe...

 truist-securities-maintains-hold-on-inspire-medical-systems-lowers-price-target-to-90

Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and lowers the price ta...

 inspire-medical-publishes-inspire-v-clinical-outcomes-data-from-singapore-clinical-study-and-limited-market-release-in-us-including-single-site-experience-at-two-leading-centers-data-to-be-presented-at-aao-hns-and-isss-meetings

Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercializat...

 evercore-isi-group-maintains-outperform-on-inspire-medical-systems-lowers-price-target-to-125

Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the p...

 kenneth-griffin-reports-58-passive-stake-in-inspire-medical-systems-as-of-sept-29

https://www.sec.gov/Archives/edgar/data/1609550/000110465925097180/xslSCHEDULE_13G_X01/primary_doc.xml

 ubs-downgrades-inspire-medical-systems-to-neutral-lowers-price-target-to-89

UBS analyst Danielle Antalffy downgrades Inspire Medical Systems (NYSE:INSP) from Buy to Neutral and lowers the price target...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION